Exhibit
2.1
ACQUISITION
AGREEMENT
BY AND AMONG
COPPERGATE COMMUNICATIONS
LTD.
SIGMA DESIGNS,
INC.
SELLING
SHAREHOLDERS
AND
CARMEL V.C. 2 LTD. AND TAMIR
FISHMAN VENTURES MANAGEMENT II LTD.,
AS THE HOLDER
REPRESENTATIVES
OCTOBER 12, 2009
|
Article
I
|
Definitions
|
8
|
|
Section
1.01
|
Certain
Definitions.
|
8
|
|
Section
1.02
|
Definitional
and Interpretative Provisions.
|
18
|
|
|
|
|
|
Article
II
|
Description of
the Transaction
|
19
|
|
Section
2.01
|
The
Transaction.
|
19
|
|
Section
2.02
|
Additional
Parties.
|
19
|
|
Section
2.03
|
Equityholders
Entitlement; Distribution.
|
21
|
|
Section
2.04
|
[Reserved].
|
28
|
|
Section
2.05
|
Escrow
Fund.
|
28
|
|
Section
2.06
|
Non Executing
Shareholders' Deposit.
|
28
|
|
Section
2.07
|
Holder
Representative Reimbursement Amount.
|
29
|
|
Section
2.08
|
Consideration
Charts.
|
29
|
|
Section
2.09
|
Legend
Requirement.
|
30
|
|
Section
2.10
|
Closing of the
Company’s Share Registry.
|
31
|
|
Section
2.11
|
Withholding
Rights.
|
31
|
|
Section
2.12
|
Treatment of
Company Options.
|
33
|
|
Section
2.13
|
Closing.
|
34
|
|
|
|
|
|
Article
III
|
Representations
and Warranties of the Company
|
35
|
|
Section
3.01
|
Corporate
Existence and Power.
|
35
|
|
Section
3.02
|
Corporate
Authorization.
|
36
|
|
Section
3.03
|
Governmental
Authorizations; Governmental Grants.
|
37
|
|
Section
3.04
|
Non-Contravention.
|
38
|
|
Section
3.05
|
Capitalization;
Subsidiaries.
|
39
|
|
Section
3.06
|
Financial
Statements.
|
41
|
|
Section
3.07
|
Absence of
Certain Changes.
|
42
|
|
Section
3.08
|
No Undisclosed
Liabilities.
|
44
|
|
Section
3.09
|
Material
Contracts.
|
45
|
|
Section
3.10
|
Compliance with
Applicable Law.
|
47
|
|
Section
3.11
|
Litigation.
|
48
|
|
Section
3.12
|
Properties.
|
48
|
|
Section
3.13
|
Inventory.
|
49
|
|
Section
3.14
|
Products and
Services.
|
50
|
|
Section
3.15
|
Customers and
Suppliers.
|
50
|
|
Section
3.16
|
Intellectual
Property.
|
50
|
|
Section
3.17
|
Insurance
Coverage.
|
54
|
|
Section
3.18
|
Tax
Matters.
|
55
|
|
Section
3.19
|
Employees and
Employee Benefit Plans.
|
58
|
|
Section
3.20
|
Environmental
Matters.
|
63
|
|
Section
3.21
|
Affiliate
Transactions.
|
63
|
|
Section
3.22
|
Finders’
Fees.
|
63
|
|
Section
3.23
|
Bank
Accounts.
|
63
|
|
Section
3.24
|
Shareholder
Vote Required.
|
64
|
|
Section
3.25
|
Company
Transaction Expense.
|
64
|
|
Section
3.26
|
Full
Disclosure.
|
64
|
|
Section
3.27
|
Disclaimer of
Other Representations and Warranties.
|
64
|
|
|
|
|
|
Article
IV
|
Representations
and Warranties of the Selling Shareholders
|
64
|
|
Section
4.01
|
Title to
Company Shares.
|
64
|
|
Section
4.02
|
Authority;
Binding Nature of Agreements.
|
65
|
|
Section
4.03
|
Non-Contravention; Consents.
|
65
|
|
Section
4.04
|
Capacity of
Selling Shareholder.
|
66
|
|
Section
4.05
|
Securities
Laws.
|
66
|
|
Section
4.06
|
Tax Withholding
Information.
|
68
|
|
Section
4.07
|
Disclosure.
|
68
|
|
Section
4.08
|
Finder’s
Fees.
|
68
|
|
|
|
|
|
Article
V
|
Representations
and Warranties of Purchaser
|
68
|
|
Section
5.01
|
Corporate
Existence and Power.
|
69
|
|
Section
5.02
|
Corporate
Authorization.
|
69
|
|
Section
5.03
|
Governmental
Authorization.
|
69
|
|
Section
5.04
|
Non-Contravention.
|
69
|
|
Section
5.05
|
SEC Filings;
Financial Statements.
|
69
|
|
Section
5.06
|
Valid
Issuance.
|
71
|
|
Section
5.07
|
Litigation.
|
71
|
|
Section
5.08
|
Compliance with
Applicable Law.
|
71
|
|
Section
5.09
|
Financial
Capacity.
|
71
|
|
Section
5.10
|
Finders’
Fees.
|
72
|
|
Section
5.11
|
Disclaimer of
Other Representations and Warranties.
|
72
|
|
|
|
|
|
Article
VI
|
Covenants of
the PARTIES
|
72
|
|
Section
6.01
|
Conduct of
Business.
|
72
|
|
Section
6.02
|
No
Solicitation; Other Offers.
|
75
|
|
Section
6.03
|
Access to
Information.
|
75
|
|
Section
6.04
|
Employee
Plans.
|
76
|
|
Section
6.05
|
Notices of
Certain Events.
|
76
|
|
Section
6.06
|
Insurance.
|
77
|
|
Section
6.07
|
Company
Debt.
|
77
|
|
Section
6.08
|
Company
Warrants.
|
77
|
|
Section
6.09
|
Restriction on
Transfer.
|
77
|
|
Section
6.10
|
Transactional
Agreements.
|
77
|
|
Section
6.11
|
Alternative
Transaction Form.
|
78
|
|
Section
6.12
|
Company
Shareholders Meeting.
|
78
|
|
|
|
|
|
Article
VII
|
Additional
Covenants of the Parties
|
78
|
|
Section
7.01
|
Commercially
Reasonable Efforts.
|
78
|
|
Section
7.02
|
Confidentiality; Public
Announcements.
|
81
|
|
Section
7.03
|
Form
S-3.
|
81
|
|
Section
7.04
|
Form
S-8.
|
84
|
|
Section
7.05
|
Bonus/
Retention Pool.
|
85
|
|
Section
7.06
|
Employee
Benefits; Other Employment Matters.
|
86
|
|
Section
7.07
|
Indemnification
of Officers and Directors.
|
86
|
|
Section
7.08
|
Nasdaq.
|
87
|
|
Section
7.09
|
Israeli
Securities Law.
|
87
|
|
Section
7.10
|
Parachute
Payments.
|
87
|
|
Section
7.11
|
Communications
with Employees.
|
87
|
|
Section
7.12
|
Resignation of
Directors.
|
87
|
|
Section
7.13
|
Option
Acknowledgment Agreements.
|
87
|
|
|
|
|
|
Article
VIII
|
Tax
Matters
|
88
|
|
Section
8.01
|
Tax
Returns.
|
88
|
|
Section
8.02
|
Cooperation.
|
89
|
|
Section
8.03
|
Tax
Contests.
|
89
|
|
Section
8.04
|
Transfer
Taxes.
|
89
|
|
|
|
|
|
Article
IX
|
Conditions to
the transactions
|
89
|
|
Section
9.01
|
Conditions to
the Obligations of Each Party.
|
90
|
|
Section
9.02
|
Conditions to
the Obligations of Purchaser.
|
90
|
|
Section
9.03
|
Conditions to
the Obligations of the Company and the Selling
Shareholders.
|
92
|
|
|
|
|
|
Article
X
|
Termination
|
93
|
|
Section
10.01
|
Termination.
|
93
|
|
Section
10.02
|
Effect of
Termination.
|
94
|
|
|
|
|
|
Article
XI
|
Indemnification
|
94
|
|
Section
11.01
|
Survival of
Representations.
|
94
|
|
Section
11.02
|
Indemnification
by Participating Rights Holders.
|
96
|
|
Section
11.03
|
Claims and
Procedures.
|
98
|
|
Section
11.04
|
Defense of
Third-Party Claims.
|
101
|
|
Section
11.05
|
No
Contribution.
|
101
|
|
Section
11.06
|
Exercise of
Remedies by Indemnitees Other Than Purchaser.
|
101
|
|
Section
11.07
|
Tax
Impact.
|
102
|
|
Section
11.08
|
Sole and
Exclusive Remedy.
|
102
|
|
Section
11.09
|
Additional
Provisions.
|
102
|
|
|
|
|
|
Article
XII
|
Holder
RepresentativeS
|
103
|
|
Section
12.01
|
Appointment of
Holder Representatives; Power and Authority.
|
103
|
|
Section
12.02
|
Reimbursement.
|
104
|
|
Section
12.03
|
Release from
Liability; Indemnification.
|
105
|
|
|
|
|
|
Article
XIII
|
Miscellaneous
|
105
|
|
Section
13.01
|
Notices.
|
105
|
|
Section
13.02
|
Remedies;
Specific Performance.
|
107
|
|
Section
13.03
|
Amendments and
Waivers.
|
107
|
|
Section
13.04
|
Expenses.
|
107
|
|
Section
13.05
|
Disclosure
Schedule References.
|
107
|
|
Section
13.06
|
Binding Effect;
Benefit; Assignment.
|
108
|
|
Section
13.07
|
Governing
Law.
|
108
|
|
Section
13.08
|
Jurisdiction;
Waiver of Jury Trial.
|
108
|
|
Section
13.09
|
Counterparts;
Effectiveness.
|
108
|
|
Section
13.10
|
Entire
Agreement.
|
109
|
|
Section
13.11
|
Attorneys’ Fees.
|
109
|
|
Section
13.12
|
Severability.
|
109
|
|
|
Applicable
Securities Compliance Definitions
|
|
|
Non-Executing
Shareholders
|
|
|
Shareholder’s Voting and Support
Agreement
|
|
|
List of
Principal Shareholders
|
|
|
Form of Letter
of Acknowledgment
|
|
|
Form of
Non-competition Agreement
|
|
|
List of
Designated Employees
|
|
|
Estimated
Consideration Allocation Chart
|
|
|
Consideration
Allocation Certificate
|
|
|
Form of Written
Declaration of Loss or Destruction of Share Certificate
|
|
|
Form of Share
Transfer Deeds
|
|
|
Form of Options
Acknowledgement Agreement
|
|
|
Company Closing
Certificate
|
|
|
Selling
Shareholder’s Certificate
|
|
|
Purchaser
Closing Certificate
|
|
|
Form of Legal
Opinion of Shenhav & Co. Law Offices, counsel to
Company
|
|
|
Form of Legal
Opinion of Herzog, Fox and Neeman, counsel to Company
|
|
|
Form of Legal
Opinion of Pillsbury Winthrop Shaw Pittman LLP, counsel to
Purchaser
|
|
|
Form of Paying
Agent Agreement
|
|
|
Form of
Resignation of Directors
|
|
|
Form of Selling
Shareholder Questionnaire
|
|
|
Form of
Assignment of Inventions Agreement
|
|
|
Letter of
Appointment of Directors
|
Company
Disclosure Schedule
ACQUISITION
AGREEMENT
THIS ACQUISITION AGREEMENT (this “
Agreement ”), dated as of October 12, 2009, is entered
into by and among CopperGate Communications Ltd., a limited
liability company under the laws of Israel (the
“Company”), Sigma Designs, Inc., a California
corporation (“ Purchaser ”), Carmel V.C. 2 Ltd.
and Tamir Fishman Ventures Management II Ltd., as the Holder
Representatives, and each of the Persons identified on Exhibit
A (the “ Executing Shareholders
”).
RECITALS
WHEREAS, the parties intend, subject to the
terms and conditions herein, to effect an acquisition by Purchaser,
directly, or indirectly through a wholly owned Israeli subsidiary
of Purchaser (the “ Acquisition Subsidiary ”),
of all of the issued and outstanding share capital of the Company,
whether by way of a share purchase of all of the issued and
outstanding share capital of the Company or by way of a merger of
Acquisition Subsidiary with the Company, as more fully described
hereinbelow;
WHEREAS, the parties intend that, subject to the
terms and conditions herein, Purchaser or the Acquisition
Subsidiary shall purchase from the Selling Shareholders, and the
Selling Shareholders shall sell, transfer assign or convey to
Purchaser or the Acquisition Subsidiary, all of the issued and
outstanding share capital of the Company;
WHEREAS, the Executing Shareholders collectively
hold and own at least 95% of the issued and outstanding Company
Shares;
WHEREAS, the Company will take reasonable
commercial efforts to cause this Agreement to be executed prior to
the Closing by the holders of Company Shares who did not execute
this Agreement at the date hereof and who are listed in Exhibit
B of this Agreement (the “ Non-Executing
Shareholders ”) (collectively with the Executing
Shareholders the “ Selling Shareholders ”) and
in such case the Company will amend Exhibit A or Exhibit
B ;
WHEREAS, the Company will take reasonable
commercial efforts to cause the Company Warrantholders to exercise
their Warrants and execute this Agreement (and in such case the
Company will amend Exhibit A or Exhibit B ) or will
terminate their rights pursuant to such securities (unless such
securities by their terms are terminated at the Closing), as
further contemplated herein;
WHEREAS, Purchaser shall have certain
indemnification rights against the Equityholders, as further set
forth in this Agreement, and will deposit with the Escrow Agent the
Escrow Fund otherwise payable by Purchaser to the Participating
Rights Holders to be held in accordance with the provisions of an
escrow agreement in the form attached hereto as Exhibit D
(the “ Escrow Agreement ”);
WHEREAS, concurrently with the execution and
delivery of this Agreement, certain Executing Shareholders listed
in Exhibit E (the “ Principal Shareholders
”) and holding at least ninety percent (90%) of the issued
and outstanding Company Shares are executing and delivering to
Purchaser a lockup agreement in the form attached hereto as
Exhibit F (the “ Lockup Agreement
”);
WHEREAS, concurrently with the execution and
delivery of this Agreement, the Key Employees listed in Schedule
1 are executing and delivering a Letter of Acknowledgment in
the form attached hereto as Exhibit G and a non-competition
agreement in the form attached hereto as Exhibit H (each, a
“ Non-competition Agreement ”);
WHEREAS, Purchaser has agreed to establish a
Retention Pool for certain Designated Employees listed in
Exhibit I as further described in this Agreement;
WHEREAS, the board of directors of the Company
(the “ Company Board of Directors ”) has
carefully considered the terms of this Agreement and has determined
that the terms and conditions of the transactions contemplated
hereby, including the Transactions, are fair and in the best
interests of, and are advisable to, the Company and the
Equityholders, and the Company Board of Directors unanimously
recommended that the Selling Shareholders vote for the approval of
this Agreement and the transactions contemplated hereby and will be
submitting the execution and delivery of this Agreement and the
performance of the transaction contemplated hereby to the Selling
Shareholders for their approval and adoption in accordance with the
Company’s Charter Documents and the Israeli Companies Law
(the “ Shareholders Meeting ”).
WHEREAS, following such recommendation of the
Company Board of Directors certain Executing Shareholders holding
an aggregate of more than ninety percent (90%) of the issued and
outstanding Company Shares signed a Shareholder’s Voting and
Support Agreement in the form attached hereto as Exhibit C
.
WHEREAS, the board of directors of Purchaser has
carefully considered the terms of this Agreement and has determined
that the terms and conditions of the transactions contemplated
hereby, including the Transactions, are fair and in the best
interests of, and are advisable to, the Purchaser and
Purchaser’s shareholders.
AGREEMENT
NOW, THEREFORE, intending to be legally bound,
the parties to this Agreement hereby agree as follows:
ARTICLE I
DEFINITIONS
Section
1.01
Certain Definitions.
As used in this Agreement, the following terms
have the following meanings:
“ Acquired Companies ” means,
collectively, the Company and each of its Subsidiaries.
“ Acquisition Proposal ”
means, other than the Transactions or any alternative transaction
proposed by Purchaser, any offer, proposal or inquiry relating to,
or any Person’s indication of interest in, (i) the sale,
license, disposition or acquisition of all or a material portion of
the business or assets of the Acquired Companies, taken as a whole,
(ii) the issuance, disposition or acquisition of (a) any shares or
other equity security of any Acquired Company (other than in
connection with the exercise or conversion of any Company Preferred
Shares, Company Option or Company Warrant), (b) any subscription,
option, call, warrant, preemptive right, right of first refusal or
any other right (whether or not exercisable) to acquire any shares
or other equity security of any Acquired Company (other than the
grant of Company Options to newly hired employees of the Company in
the ordinary course of business consistent with past practices), or
(c) any security, instrument or obligation that is or may become
convertible into or exchangeable for any shares or other equity
security of any Acquired Company or (iii) any merger,
consolidation, business combination, reorganization or similar
transaction involving any Acquired Company.
“ Acquisition Transaction ”
means any transaction or series of transactions
involving:
(i) the
sale, license or disposition of all or a material portion of any
Acquired Company’s business or assets;
(ii) the
issuance, disposition or acquisition of: (i) any capital stock or
other equity security of an Acquired Company; (ii) any option,
call, warrant or right (whether or not immediately exercisable) to
acquire any capital stock, unit or other equity security of an
Acquired Company; or (iii) any security, instrument or obligation
that is or may become convertible into or exchangeable for any
capital stock, unit or other equity security of an Acquired
Company; or
(iii) any
merger, consolidation, business combination, reorganization or
similar transaction involving an Acquired Company.
“ Affiliate ” means, with
respect to any Person, any other Person directly or indirectly
controlling, controlled by, or under common control with such
Person. For purposes of this definition, “control,”
when used with respect to any specified Person, means the power to
direct or cause the direction of the management and policies of
such Person, directly or indirectly, whether through ownership of
voting securities or by contract or otherwise, and the terms
“controlling” and “controlled by” have
correlative meanings to the foregoing.
“ Aggregate Consideration Shares
” or "Consideration Shares" the lesser of (a) the Base
Line Number of Consideration Shares and (b) the Maximum
Consideration Shares (as of the date of the execution of this
Agreement 5,085,736).
“ Aggregate Consideration Value
” means (i) the Aggregate Consideration Shares multiplied by
the Closing SD Share Price, plus (ii) the Closing Cash
Consideration, minus the Vested Option Adjustment
Amount.
“ Applicable Law ” means,
with respect to any Person, any Israeli, U.S. federal, state,
local, municipal, foreign or other law (including common law),
statutes, regulations, written regulatory guidance, directives,
constitution, treaty, convention, ordinance, code, rule,
regulation, order, injunction, judgment, decree, ruling, request or
other similar requirement enacted, adopted, promulgated or applied
by a Governmental Authority that is binding upon or applicable to
such Person, as amended unless expressly specified
otherwise.
“ Average SD Share Price ”
means $14.986 per each Consideration Share.
“ Balance Sheet ” means the
reviewed balance sheet of the Company as of June 30,
2009.
“ Balance Sheet Date ” means
June 30, 2009.
“ Base Line Number of Consideration
Shares ” means 5,338,316 shares of Purchaser’s
Shares.
“ Business Day ” means a day,
other than Saturday, Sunday or other day on which commercial banks
in San Francisco, California, USA or Tel Aviv, Israel are
authorized or required by Applicable Law to close.
“ Cash ” means cash
(including short or long term bank deposits) and Cash Equivalents
determined in accordance with GAAP and calculated net of issued but
uncleared checks and drafts and shall include checks, wire
transfers and drafts deposited or available for deposit.
“ Cash Equivalents ” means
investment securities with original maturities (calculated as of
the Closing Date) of 12 months or less, including all funds held in
money market or similar accounts, including interest accrued
thereon as of the Closing.
“ Closing Cash Consideration
” means (i) $80,000,000 plus (ii) the Vested Options
Adjustment Amount, plus (iii) the Share Adjustment Amount (as of
the date of execution an amount equal to $3,785,164)
plus (iv) an amount equal to the
Company Cash minus an amount equal to the Company Debt
minus the Company Transaction Expenses set forth in the
Company Transaction Certificate.
“ Closing Consideration Shares
” means the Aggregate Consideration Shares minus the number
of Phantom Shares minus the number of Purchaser's Equity Awards
(i.e. the total number of Consideration Shares issued at the
Closing to the Selling Shareholders in connection with the
Transaction contemplated hereby).
“ Closing SD Share Price ”
means the average closing price of a Purchaser’s Share on the
Nasdaq Global Select Market for the 30-day trading period in which
the last day will be the third Business Date prior to the Closing
Date.
“ Code ” means the United
States Internal Revenue Code of 1986, as amended.
“ Company Cash ” means the
aggregate amount of all Cash of the Acquired Companies as of the
close of business on the day immediately preceding the Closing
Date.
“ Company Debt ” means both
the current and long-term portions of any amount owed by any of the
Acquired Companies (including all outstanding principal, prepayment
premiums, penalties and similar amounts, if any, and accrued but
unpaid interest, fees and expenses related thereto) in respect of
borrowed money from third parties (e.g. excluding any inter-company
financing arrangements) from third parties.
“ Company Disclosure Schedule
” means the disclosure schedule dated the date of this
Agreement regarding this Agreement that has been delivered by the
Company to Purchaser.
“ Company IP ” means any and
all Intellectual Property Rights owned by any Acquired
Company.
“ Company IP Contract ” means
any Contract to which any Acquired Company is party
or by which any Acquired Company is bound, that
contains any sale, assignment or license of, or covenant not to
assert or enforce, or release of, any Intellectual Property Right,
including any Company IP.
“ Company Material Adverse Effect
” Any event, change, development or state of facts having a
material adverse effect on the business, assets, Company IP,
liabilities, operations, results of operations or financial
condition of the Acquired Companies, taken as a whole;
provided , however , that no (i) event,
change, development or state of facts relating to the economy or
financing or capital markets in general or resulting from
industry-wide developments in the semiconductor or IPTV industries
or generally affecting geographical areas in which any of the
Acquired Companies conducts its business (but only to the extent
such events, changes, developments or states of facts do not,
individually or in the aggregate, have a disproportionate impact on
the Acquired Companies, taken as a whole, relative to
other Persons in the semiconductor industry or in such applicable
geographical areas in which any of the Acquired Companies conducts
its business), (ii) event, change, development or state of facts
directly related to the announcement, execution, performance or
pendency of this Agreement and the Transactions, including the
impact thereof on relationships, contractual or otherwise, with
customers, suppliers, distributors or partners, or resulting
shortfalls or declines in revenue, margins or profitability (iii)
change in accounting requirements in accordance with GAAP, (iv) any
natural disaster or any acts of military action or war (whether or
not declared), sabotage, terrorism or any escalation or worsening
thereof, occurring or commenced after the date of this Agreement
(but only to the extent such disaster or acts do not, individually
or in the aggregate, have a disproportionate impact on the Acquired
Companies, taken as a whole, relative to other
Persons similarly affected by such disaster or acts), (v) changes
in Applicable Law; or (vi) actions by Purchaser, Company or any of
the Equityholders required to be taken pursuant to this Agreement
(including the consummation of the Transactions), shall be deemed,
each individually, to constitute a Company Material Adverse
Effect.
“ Company Option ” shall have
the meaning ascribed to it in Section 2.12(a) hereof.
“ Company Optionholder ”
means a holder of a Company Option.
“ Company Option Plan ” means
the Company’s 2000 Israel Share Incentive Plan, the
Company’s 2003 Share Option Plan and the 2007 U.S. Appendix
thereto, each as amended from time to time.
“ Company Ordinary Shares ”
means the ordinary shares of the Company, nominal value NIS 0.10
each.
“ Company Ordinary A Shares ”
means the ordinary A shares of the Company, nominal value NIS 0.10
each.
“ Company Preferred Shares ”
means the preferred shares of the Company, including the Preferred
A-1 Shares, the Preferred A-3 Shares, the Preferred B Shares, the
Preferred C Shares and the Preferred D Shares.
“ Company Product ” means
each product developed, manufactured, marketed, licensed by, sold,
performed, offered, distributed or otherwise made available,
currently or previously, by or on behalf of any Acquired Company,
including any product currently or previously under development by
any Acquired Company, and any and all services currently or
previously provided by or for any Acquired Company with respect to
such Company Products or provided as a separate service
“ Company Shares ” means
collectively, the Company Ordinary Shares, the Company Ordinary A
Shares and the Company Preferred Shares.
“ Company Trade Secrets ”
means all Trade Secrets owned by any Acquired Company.
“ Company Transaction Expenses
” means the total amount of fees, costs and expenses of any
nature that is payable by any Acquired Company to outside legal
counsel and any financial advisor, accountant or other Person who
performed services for or on behalf of any Acquired Company, or who
is otherwise entitled to any compensation from any Acquired
Company, in connection with this Agreement or any of the
transactions contemplated by this Agreement and not paid prior to
the Closing.
“ Company Warrantholder ”
means a holder of a Company Warrant.
“ Company Warrants ” means
each warrant or other contractual right to purchase or acquire
Company Shares other than Company Options.
“ Consent ” means any
approval, consent, ratification or permission.
“ Consideration Allocation
Certificate ” means a spreadsheet that shall be delivered
to the Purchaser 3 days prior to the Closing Date and shall set
forth, as of the Closing Date and immediately prior to the Closing,
the following factual information relating to each Equityholder:
(i) the names of all of the holders of Company Shares and holders
of Vested Company Options, their street addresses, e-mail address,
telephone number, Israeli identification numbers (if available),
bank information (the respective bank name and number, the branch
name, number and address, swift number and account number); (ii)
the number (and class) of Company Shares held by each holder of
Company Shares; (iii) the number of Vested Company Options and
Unvested Company Options held by each Company Optionholder and the
number of underlying Company Shares into which the Vested Company
Options are exercisable assuming a cashless exercise of such Vested
Company Options; (iv) a calculation of the Closing Cash
Consideration and the portion payable to each Selling Shareholder
and each holder of Vested Company Options; (v) a calculation of the
number of Closing Consideration Shares, Phantom Shares and
Purchaser's Equity Awards each Equityholder is entitled to receive
pursuant to the terms of this Agreement; (vi) the Cash Component of
the Escrow Fund and the Share Component of the Escrow Fund to be
delivered to the Escrow Agent and a calculation of each
Participating Rights Holder’s Interest; and (vii) the Rep
Reimbursement Amount, and (viii) the calculation of each
Participating Rights Holder’s Interest in the Rep
Reimbursement Amount and in the Escrow Fund.
“ Contract ” means any
oral or written contract, agreement, understanding, undertaking,
indenture, note, or bond pursuant to which an Acquired Company is a
party.
“ Damages ” include any
direct liability, loss, damage, injury, claim, demand, settlement,
judgment, award, fine, penalty, fee (including reasonable
attorneys’ fees), charge, cost (including reasonable costs of
investigation) or expense of any nature.
“ Designated Employees ”
means the Persons identified on Exhibit I .
“ Environmental Laws ” means
any Applicable Law or any agreement with any Governmental Authority
or other Person, relating to human health and safety, the
environment or to Hazardous Substances.
“ Environmental Permits ”
means all permits, licenses, franchises, certificates, approvals
and other similar authorizations of Governmental Authorities
relating to or required by Environmental Laws and affecting, or
relating in any way to, the business of the Acquired Companies as
currently conducted.
“ Equityholders ” means the
Selling Shareholders, the Company Warrantholders and the Company
Optionholders.
“ ERISA ” means the Employee
Retirement Income Security Act of 1974.
“ ERISA Affiliate ” of any
entity means any other entity which, together with such entity,
would be treated as a single employer under Section 414 of the
Code.
“ Escrow Agent ” means UBank
Trust Company Ltd.
“ Escrow Fund ” means (i)
with respect to holders of issued and outstanding Company Shares
immediately prior to the Closing, an amount in US$ equal to 10% of
the Closing Cash Consideration and that number of Purchaser’s
Shares equal to 10% of the Closing Share Consideration payable to
all such holders pursuant to this Agreement, and (ii) with respect
to holders of issued and outstanding Vested Company Options
immediately prior to the Closing, an amount in US$ equal to 10% of
the Closing Cash Consideration payable to all such holders pursuant
to this Agreement.
“ Estimated Consideration Allocation
Chart ” means a spreadsheet that shall be dated as of the
date of this Agreement and shall set forth the following factual
information relating to each Equityholder: (i) the names of the
Equityholder; (ii) the number (and class) of Company Shares held by
each holder of Company Shares; (iii) the number of Vested Options
and Unvested Options held by each Company Optionholder, the
exercise price of such options, the number of underlying Company
Shares into which the Vested Options are exercisable assuming a
cashless exercise of the Vested Options (iv) the number of Company
Warrants held by each Company Warrantholder and the number (and
class) of Company Shares the Company Warrants may be exercised into
(based both on a cash and a cashless exercise, such cashless
exercise calculation to be based on the Per Share Ordinary Amount;
(v) an estimation of the Company Cash and the Closing Cash
Consideration and the portion payable to each Selling Shareholder
and each holder of Vested Company Options; (vi) a calculation of
the number of Closing Consideration Shares, Phantom Shares and
Purchaser's Equity Awards each Equityholder is entitled to receive
pursuant to the terms of this Agreement; (vii) the Cash Component
of the Escrow Fund and the Share Component of the Escrow Fund to be
delivered to the Escrow Agent and a calculation of each
Participating Rights Holder’s Interest; (viii) the Rep
Reimbursement Amount; and (ix) the calculation of each
Participating Rights Holder’s Interest in the Rep
Reimbursement Amount and in the Escrow Fund.
“ Exchange Act ” means the
Securities Exchange Act of 1934, as amended.
“ GAAP ” means generally
accepted accounting principles in the United States, consistently
applied throughout the respective periods covered.
“ Governmental Authority ”
means any: (i) nation, state, commonwealth, province,
territory, county, municipality, district or other jurisdiction of
any nature; (ii) Israeli, U.S. federal, state, local,
municipal, foreign or other government; (including any governmental
division, department, agency, commission, instrumentality,
official, organization, unit, body or Person and any court or other
tribunal).
“Governmental
Authorization” means any permit, license, certificate,
franchise, permission, clearance, registration, qualification or
authorization issued, granted, given or otherwise made available by
or under the authority of any Governmental Authority.
“Governmental Grant
” means any grant, incentive,
subsidy, award, participation, exemption, status, cost sharing
arrangement, reimbursement arrangement or other benefit, relief or
privilege provided or made available by or on behalf of or under
the authority of the Chief Scientist, the Investment Center, the
State of Israel, the BIRD Foundation and other bi- or
multi-national grant programs for research and development, the
European Union, the Fund for Encouragement of Marketing Activities
of the Israeli Government or any other Governmental
Authority.
“ Hazardous Substances ”
means any pollutant, contaminant, waste or chemical or any toxic,
radioactive, ignitable, corrosive, reactive or otherwise hazardous
substance, waste or material, or any substance, waste or material
having any constituent elements displaying any of the foregoing
characteristics, including petroleum, its derivatives, by-products
and other hydrocarbons, and any substance, waste or material
regulated under any Environmental Law.
“ Intellectual Property Rights
” means all of the following forms of intellectual property
rights arising under the laws of Israeli, United States or any
other jurisdiction with respect thereto: (i) any and all classes
and types of patents, utility models and design patents
and applications for these classes and types of patent
rights and all disclosures relating thereto (and any patents that
issue as a result of those patent applications), and any renewals,
reissues, reexaminations, extensions, continuations,
continuations-in-part, divisions and substitutions relating to any
of the patents and patent applications, as well as all related
foreign patent and patent applications that are counterparts to
such patents and patent applications, (ii) trademarks, service
marks, trade dress, logos, trade names and corporate names, whether
registered or unregistered, and the goodwill associated therewith,
together with any registrations, applications for registration,
renewals and extensions thereof, (iii) copyrights and rights under
copyrights (including software), whether registered or
unregistered, including moral rights and any other rights in works
of authorship, and any registrations and applications for
registration thereof, (iv) mask work rights and registrations and
applications for registration thereof, (v) rights in databases and
data collections (including knowledge databases, customer lists and
customer databases), whether registered or unregistered, and any
applications for registration therefor, (vi) Trade Secrets, (vii)
URL and domain name registrations and (viii) all claims, causes of
action and rights to sue or recover and claim damages arising out
of or related to the past, present or future infringement or
misappropriation of any of the foregoing.
“ Investment Center ” means
the Investment Center of the Israeli Ministry of Industry, Trade
and Labor established under the Israel Law for the Encouragement of
Capital Investments, 1959.
“ IRS ” means the United
States Internal Revenue Service.
“ ISA ” means the Israeli
Securities Authority.
“ Israeli Code ” means the
Income Tax Ordinance of Israel New Version, 1961, as amended, and
the rules and regulations promulgated thereunder.
“ Israeli Companies Law ”
means the Israeli Companies Law, 1999, as amended and the rules and
regulations promulgated thereunder.
“ Israel Securities Law ”
means the Israel Securities Law, 1968, as amended, and the rules
and regulations promulgated thereunder.
“ ITA ” means the Israel Tax
Authority established pursuant to the Israeli Code.
“ Key Employees ” means the
Persons identified on Schedule 1 .
“ Knowledge ” means, (i) with
respect to the Company, the actual knowledge of each of the Key
Employees and any knowledge that each of such individuals should
have obtained after reasonable inquiry in the course of the
performance of their respective duties on behalf of any Acquired
Companies; provided, however, that for purposes of Section 3.16
below, reasonable inquiry shall not include a “freedom to
operate” study, and, (ii) with respect to the Purchaser, the
actual knowledge of each of the Chief Executive Officer and Chief
Financial Officer of Purchaser and any knowledge that each of such
individuals should have obtained after reasonable inquiry in the
course of the performance of their respective duties on behalf of
the Purchaser, and (iii) with respect to each Selling Shareholder
that is not an individual, the Chief Executive Officer (in case of
a company), or General Partner (in case of a partnership), of such
Selling Shareholders and any knowledge that each of such
individuals should have obtained after reasonable inquiry in the
course of the performance of their respective duties on behalf
of the relevant Selling Shareholder.
“ Lien ” means, with respect
to any property or asset, any mortgage, lien, pledge, charge,
security interest, encumbrance or other adverse claim of any kind
in respect of such property or asset. For purposes of this
Agreement, a Person shall be deemed to own subject to a Lien any
property or asset that it has acquired or holds subject to the
interest of a vendor or lessor under any conditional sale
agreement, capital lease or other title retention agreement
relating to such property or asset.
“ Maximum Consideration Shares
” means the lesser of (i) 5,085,736 shares of
Purchaser’s Shares, or (ii) such number of Purchaser's Shares
representing 19.0% of the issued and outstanding capital stock of
the Purchaser immediately prior to the Closing (as provided by
Purchaser to the Company by a certificate signed by the Chief
Executive Officer or Chief Financial Officer of Purchaser at least
three (3) Business Days prior to the Closing).
“ OCS ” means the Office of
the Chief Scientist of the Israeli Ministry of Industry, Trade and
Labor.
“ Open Source Software ”
means any software code that is either (a) distributed under a
license approved by the Open Source Initiative, (b)
described as “free software” or “open source
software,” or (c) otherwise distributed in source code form
under terms requiring as a condition of use, modification and/or
distribution of such software that other software incorporated
into, derived from or distributed with such software (1) be
disclosed or distributed in source code form, (2) be licensed for
the purpose of making derivative works, (3) be redistributable at
no charge, (4) licensed under terms that allow such software or
portions thereof or interfaces therefor to be reverse engineered,
reverse assembled or disassembled (other than as provided under
Applicable Law), or (5) grants to any third party any rights to or
immunities under any Intellectual Property Rights (other than as
provided under Applicable Law). Open Source Software includes
software code licensed under the GNU General Public License, GNU
Lesser General Public License, Mozilla Public License, Apache
License, BSD License, MIT License, Artistic License, Common
Development and Distribution License, Common Public License,
Eclipse Public License, and similar licenses.
“ Phantom Shares ” means
Purchaser's Shares that would have been issued to the holders of
Vested Company Options as further described in Section 2.03(b)
below.
“ Paying Agent ” means UBank
Trust Company Ltd.
“ Participating Rights Holder
” means holder of Company Shares and holder of Vested Company
Options.
“ Participating Rights Holder’s
Interest ” means the percentage interest of each
Participating Rights Holder in the Escrow Fund (calculated pursuant
to the formula set forth in Section 2.05(c) below) and in the Rep
Reimbursement Amount.
“ Person ” means an
individual, corporation, partnership, limited liability company,
association, trust or other entity or organization, including a
Governmental Authority.
“ Pre-Closing Tax Period ”
means (i) any Tax period ending before the Closing Date and (ii)
with respect to any Straddle Period, the portion of such period
ending at the close of business on the day prior to the Closing
Date.
“ Preferred A-1 Shares ”
means the Preferred A-1 Shares of the Company, nominal value NIS
0.01 each.
“ Preferred A-3 Shares ”
means the Preferred A-3 Shares of the Company, nominal value NIS
0.01 each.
“ Preferred B Shares ” means
the Preferred B Shares of the Company, nominal value NIS
0.01 each.
“ Preferred C Shares ” means
the Preferred C Shares of the Company, nominal value NIS
0.01 each.
“ Preferred D Shares ” means
the Preferred D Shares of the Company, nominal value NIS 0.01
each.
“ Proceeding ” means any
action, suit, litigation, arbitration, proceeding (including any
civil, criminal, administrative, investigative or appellate
proceeding), hearing, inquiry, audit, examination or investigation
commenced, brought, conducted or heard by or before, or otherwise
involving, any court or other Governmental Authority or any
arbitrator or arbitration panel.
"Purchaser's Equity Awards" shall have the
meaning as set forth in Section 2.03(c).
“ Purchaser Indemnitees ”
means the following Persons: (i) Purchaser; (ii) the Acquired
Companies; (iii) the respective Representatives of the Persons
referred to in clauses “(i)” and “(ii)”
above; and (iv) the respective successors and assigns of the
Persons referred to in clauses “(i),”
“(ii)” and “(iii)” above.
“ Purchaser Material Adverse Effect
” means any event, change, development or state of facts
having a material adverse effect on the business, assets,
liabilities, operations or financial condition of Purchaser, taken
as a whole; provided , however , that
no (i) event, change, development or state of facts relating to the
economy or financing or capital markets in general, or resulting
from industry-wide developments in the semiconductor or IPTV
industries or generally affecting geographical areas in which
Purchaser or any of its Subsidiaries conducts its business (but
only to the extent such events, changes, developments or states of
facts do not, individually or in the aggregate, have a
disproportionate impact on Purchaser or any of its Subsidiaries,
taken as a whole, relative to other Persons in the
semiconductor industry or in such applicable geographical areas in
which Purchaser conducts its business), (ii) event, change,
development or state of facts directly related to the announcement,
execution, performance or pendency of this Agreement and the
Transactions, including the impact thereof on relationships,
contractual or otherwise, with customers, suppliers, distributors
or partners, or resulting shortfalls or declines in revenue,
margins or profitability (iii) change in accounting requirements in
accordance with GAAP, (iv) a any natural disaster or any acts of
military action or war (whether or not declared), sabotage,
terrorism or any escalation or worsening thereof, occurring or
commenced after the date of this Agreement (but only to the extent
such disaster or acts do not, individually or in the aggregate,
have a disproportionate impact on Purchaser or any of its
Subsidiaries, taken as a whole, relative to other
Persons similarly affected by such disaster or acts), (v) changes
in Applicable Law; or (vi) actions by Purchaser, Company or any of
the Equityholders required to be taken pursuant to this Agreement
(including the consummation of the Transactions), shall be deemed,
each individually, to constitute a Purchaser Material Adverse
Effect.
“ Purchaser’s Share(s)
” means shares of Purchaser’s common stock, no par
value.
“ Registered IP ” means all
Company IP with respect to which any registration, application,
certificate, filing or other document has been issued by, filed
with, or recorded by, any private, state, government or other
public or quasi-public legal authority in connection with the
protection of Intellectual Property Rights, including patents,
domain names, registered copyrights (including registered mask
works), and registered trademarks and all applications for any of
the foregoing.
“ Representatives ” means a
Person’s officers, directors, employees, agents, attorneys,
accountants, advisors, investment bankers and other representatives
(and in case of a partnership, its general partner).
“ SEC ” means the United
States Securities and Exchange Commission.
“ Securities Act ” means the
Securities Act of 1933, as amended.
“ Share Adjustment Amount ”
means, if the Maximum Consideration Shares is lower than the
B ase Line Number of Consideration Shares, an amount equal
to the product of (i) the Average SD Share Price multiplied by (ii)
the difference of Base Line Number of Consideration Shares minus
the Maximum Consideration Shares (as of the date of execution of
this Agreement $3,785,164 calculated by multiplying 252,580 shares
of Purchaser's Shares multiplied by the Average SD Share Price). If
the Maximum Consideration Shares is not lower than the Base Line
Number of Consideration Shares, then the Share Adjustment Amount
shall be zero.
“ Specified Representations
” means the representations and warranties set forth in
Section 3.01, Section 3.02, Section 3.05, Section 4.01 and Section
4.02, and the information and calculations set forth on the
Consideration Allocation Certificate.
“ Straddle Period ” means any
Tax period beginning before the Closing Date and ending on or after
the Closing Date.
“ Subsidiary ” means, with
respect to any Person, any entity of which securities or other
ownership interests having ordinary voting power to elect a
majority of the board of directors or other persons performing
similar functions are at any time directly or indirectly owned by
such Person.
“ Tax ” means any and all
taxes, including (i) any net income, gross income, gross receipts,
branch profits, sales, use, value added, transfer, franchise,
profits, license, registration, documentary, conveyancing, gains,
withholding, national insurance ( ‘bituach leumi
’), national health insurance ( ‘bituach
briyut’ ) and other payroll taxes, employment, excise,
severance, stamp, occupation, premium, property, environmental or
windfall profit, custom duty, escheat or other tax, governmental
fee or other like assessment or charge of any kind whatsoever,
together with any interest, inflation linkage ( ‘hefreshei
hatzmada ’), penalty, addition to tax or additional
amount imposed by any governmental authority responsible for the
imposition of any such tax (Israeli, United States (federal, state
or local) or foreign).
“ Tax Contest ” means any
audit (by any Governmental Authority), other administrative
proceeding or inquiry or judicial proceeding involving
Taxes.
“ Tax Return ” means any
return, report, declaration, claim for refund, information return
(including schedules thereto, other attachments thereto, amendments
thereof) filed or required to be filed with any Tax authority in
connection with the determination, assessment or collection of any
Tax, or the administration of any laws, regulations or
administrative requirements relating to any Tax.
“ Technology ” means all
tangible or intangible embodiments of the Company IP owned by any
Acquired Company which are incorporated in any Company
Products.
“ Trade Secrets ” means all
inventions (whether or not patentable) and improvements thereto,
know-how, research and development information, business plans,
specifications, designs, processes, process libraries, technical
data, customer data, financial information, pricing and cost
information, bills of material, or other confidential information
exclusively owned by a Person, including any formula, pattern,
compilation, program, device, method, technique, or process, that
(i) provides an actual or potential independent economic value from
not being generally known to and not being readily ascertainable
by, other Persons, and (ii) is the subject of efforts that are
reasonable under the circumstances to maintain its secrecy and for
which those efforts resulted in a reasonable belief that sufficient
secrecy was maintained.
“ Transactional Agreements ”
means this Agreement, the Company Closing Certificate, the
Consideration Allocation Certificate, the Transaction Expenses
Certificate, the Closing Cash Certificate, the Selling Shareholder
Certificate, the Escrow Agreement, the Lockup Agreements, the
Option Acknowledgment Agreement, the Paying Agent Agreement, the
Non-competition Agreements and the Letter of
Acknowledgment.
“ Transactions ” means the
purchase of the Company Shares by Purchaser, the payment for the
termination or waiver of Company Warrants, the exchange of Vested
Company Options for cash, the assumption of Unvested Company
Options, and the other transactions contemplated by this
Agreement.
“ Trustee ” means Tamir
Fishman Trusts 2004 Ltd. appointed by the Company for the purpose
of the Company’s “Section 102 Plan”.
“ Vested Options Adjustment Amount
” means an amount equal to total number of Phantom Shares
multiplied by the Closing SD Share Price.
Section
1.02
Definitional and Interpretative Provisions .
(a) The
words “hereof,” “herein” and
“hereunder” and words of like import used in this
Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement.
(b) The
captions herein are included for convenience of reference only and
shall be ignored in the construction or interpretation hereof.
References to Articles, Sections, Exhibits and Schedules are to
Articles, Sections, Exhibits and Schedules of this Agreement unless
otherwise specified.
(c) All
Exhibits and Schedules annexed hereto or referred to herein are
hereby incorporated in and made a part of this Agreement as if set
forth in full herein. Any capitalized terms used in any Exhibit or
Schedule but not otherwise defined therein, shall have the meaning
as defined in this Agreement.
(d) Any
singular term in this Agreement shall be deemed to include the
plural, and any plural term the singular.
(e) Whenever
the words “include,” “includes” or
“including” are used in this Agreement, they shall be
deemed to be followed by the words “without
limitation,” whether or not they are in fact followed by
those words or words of like import.
(f) All
references to time shall refer to New York City time. The word
“extent” in the phrase “to the extent”
means the degree to which a subject or other thing extends, and
such phrase shall not mean simply “if”.
(g) The
use of the word “or” shall not, necessarily, be
exclusive.
(h) Any
rule of construction to the effect that ambiguities are to be
resolved against the drafting party shall not be applied in the
construction or interpretation of this Agreement.
(i) Any
agreement or instrument defined or referred to herein, or in any
agreement or instrument that is referred to herein, means such
agreement or instrument as from time to time amended, modified or
supplemented. Other terms may be defined elsewhere in the text of
this Agreement and shall have the meaning indicated throughout this
Agreement.
(j) The
term “foreign” when used with respect to Applicable Law
or a Governmental Authority shall refer to all jurisdictions other
than Israel or the United States.
(k) The
term “Dollar”, “$”, or USD shall refer to
the currency of the United States of America. When such reference
is made and the actual liability or payment is set in Israeli New
Shekels, for purpose of this Agreement, the representative rate of
exchange published by the Bank of Israel on the day prior to the
day on which the calculation is made, unless otherwise specified
herein.
ARTICLE II
DESCRIPTION OF THE
TRANSACTION
Section
2.01
The Transaction .
(a)
Sale and Purchase of Shares . Subject to the terms and
conditions of this Agreement, at the Closing: (i) the Selling
Shareholders, severally and not jointly, shall sell, assign,
transfer and deliver the Company Shares to Purchaser, and Purchaser
shall purchase the Company Shares from the Selling Shareholders;
(ii) Company Warrants outstanding as of the Closing Date will be
waived or terminated; (iii) the Purchaser shall exchange all Vested
Company Options for cash and (iv) the Purchaser shall assume the
Unvested Company Options in exchange for the Purchaser's Equity
Awards in accordance with the terms of this Agreement, and subject
to adjustments and withholdings as set forth in this
Agreement.
(b)
Shareholder’s Voting and Support Agreement . At or
prior to the date hereof, Executing Shareholders holding at least
ninety percent (90%) of the issued and outstanding Company Shares
executed a Shareholder’s Voting and Support Agreement in the
form attached hereto as Exhibit C (the “
Shareholder’s Voting and Support Agreement
”). The Company shall use reasonable commercial
efforts to cause each other Executing Shareholder to execute a
Shareholder’s Voting and Support Agreement.
Section
2.02
Additional Parties .
(a)
Execution of Agreement by Additional Parties . Promptly
after the date of execution of this Agreement and for as long as
this Agreement is not duly terminated, the Company shall take
reasonable commercial efforts to obtain from all Non-Executing
Shareholders, a counter signature on this Agreement under which
each such Non-Executing Shareholder becomes bound by and subject to
the provisions of this Agreement as an Executing Shareholder. The
Company agrees to communicate promptly to the Purchaser any update
to the Company’s efforts to obtain a counter signature on
this Agreement from a Non-Executing Shareholder or any material
communication with any Non-Executing Shareholder regarding the
execution of this Agreement by such Non-Executing
Shareholder. At any time on or before the Closing,
Purchaser, the Company and the Holder Representatives may amend
Exhibit A , without the consent of the Executing
Shareholders, to include as parties any Equityholders of the
Company not listed on Exhibit A on the date of this
Agreement, including all Non-Executing Shareholders as well as
Company Warrantholders and holders of Vested Company Options who
exercised their respective Company Warrants or Company Options.
Such additional Equityholders shall be deemed to be “Selling
Shareholders” for all purposes of this Agreement, and any
Company Ordinary Shares, Company Ordinary A Shares or Company
Preferred Shares owned by such shareholders shall be deemed to be
“Company Shares”.
(b)
Section 341 of the Israeli Companies Law; Bring Along
.
(1) By
executing this Agreement, the Executing Shareholders, who
collectively hold at least 95% of the issued and outstanding share
capital of the Company, have, and are deemed to have, accepted an
offer by Purchaser to purchase their shares in accordance with the
terms set forth in this Agreement, in accordance with Section 341
of the Israeli Companies Law and Article 50 of the Company’s
Articles of Association.
(2) This
Agreement shall be deemed, for the purpose of Section 341(a) of the
Israeli Companies Law and Article 50 of the Company’s
Articles of Association to constitute (i) an offer by Purchaser for
the purchase of all issued and outstanding share capital of the
Company which is conditioned upon the sale of all of the
outstanding share capital of the Company and (ii) an acceptance of
such offer by all Executing Shareholders who have duly executed
this Agreement initially or pursuant to Section 2.2(a)(i)
above.
(3) Promptly
(but in any event within two (2) Business Days) following the date
of this Agreement, Purchaser will, in accordance with Section
341(a) of the Israeli Companies Law and Article 50.1 of the
Company’s Articles of Association, provide a written notice
in the form to be agreed upon by Purchaser and the Company, (the
“ Bring-Along Notice ”) to each Non-Executing
Shareholder that has not duly executed and delivered this Agreement
or countersigned this Agreement in accordance with Section
2.2(a)(i) setting forth the information required by Section 341(a)
of the Israeli Companies Law and Article 50.1 of the
Company’s Articles of Association and stating that
Purchaser’s requirement to purchase such Non-Executing
Shareholder’s Company Shares under the terms and conditions
of this Agreement. The Company shall assist Purchaser to dispatch
the Bring-Along Notice to each Non-Executing Shareholder. Purchaser
and Company shall fully coordinate any correspondence to which each
may be a party which concerns the Bring-Along Notice. Purchaser and
the Company shall take such other actions as may be commercially
reasonably appropriate in order to complete the transfer of all of
the outstanding Company Shares pursuant to Section 341 of the
Israeli Companies Law and Article 50 of the Company’s
Articles of Association and under the terms and conditions of this
Agreement, including in making all reasonable filings and taking
such other reasonable action which is necessary or desirable to
effect the Transactions with respect to all the securities of the
Company outstanding as of the Closing in compliance with
Section 341 of the Israeli Companies Law and Article 50 of the
Company’s Articles of Association. After satisfactory
completion of the necessary procedures under Section 341 of the
Israeli Companies Law and Article 50.1 of the Company’s
Articles of Association, and provided that no injunction against
the Transactions was issued by a court of competent jurisdiction
that was not subsequently removed, at the Closing the Company shall
register Purchaser as owner of all the shares of the Company held
by all Non-Executing Shareholders as of the Closing against
delivery by Purchaser to the Company of the portion of the Closing
Cash Consideration and the number of the Closing Consideration
Shares payable or issuable, as the case may be, with respect to the
Company Shares held by the Non-Executing Shareholders, less such
Non-Executing Shareholder’s portion of the Escrow Fund to be
held in escrow by the Escrow Agent, and paid to the Non-Executing
Shareholders following the Closing.
(4) Subject
to the terms of this Agreement, following the execution of this
Agreement and prior to the Closing Date, if the Company shall issue
any shares pursuant to the exercise of any Company Options, Company
Warrants or any other convertible securities, then the Company
shall promptly: (i) inform Purchaser of such an issuance, and (ii)
amend Exhibit B so that such Person will be deemed, for
purposes of this Agreement a Non-Executing Shareholder; and (iii)
use commercially reasonable efforts to obtain from such holder of
Company Shares, a counter signature on this Agreement under which
he, she or it becomes bound by and subject to the provisions of
this Agreement as an Executing Shareholder (and amend Exhibit
A accordingly); and (iv) if such a Person does not execute this
Agreement, assist Purchaser, to the extent necessary, in the
dispatch of a Bring-Along Notice to such new Non-Executing
Shareholders such that said notice will cover all issued and
outstanding share capital of the Company.
(5) For
purposes of this Agreement, the term “Selling
Shareholder” shall include all Non-Executing Shareholders and
each such Non-Executing Shareholder shall be deemed to be subject
to the terms and conditions of this Agreement, except to the extent
that doing so would be inconsistent with the provisions of Section
341 of the Israeli Companies Law.
(6) For
the sake of clarity, Purchaser may elect, in its sole discretion,
no later than five (5) Business Days after the alternative
transaction deadline date as set forth in Section 6.11 below, the
alternative transaction form under Section 6.11 hereof, in lieu of
the bring-along contemplated under this Section 2.02(b), and is not
deemed for any purposes whatsoever to be bound to consummate the
acquisition of the Company by way of said bring-along
provisions.
(c)
Company Warrants . At the Closing, the outstanding Company
Warrants will either be terminated or exercised into Company
Shares. The number of and class of Company Shares each
Warrantholder will be entitled to receive upon exercise or
termination of such Warrants (calculated on a cashless basis) shall
be set forth in the Estimated Consideration Allocation Chart and
the Consideration Allocation Certificate. For purposes of this
Agreement, the term “Selling Shareholder” shall include
all holders of Company Warrants.
Section
2.03
Equityholders Entitlement; Distribution .
Out of the Aggregate Consideration, each
Equityholder shall be entitled to receive the following:
(a)
Selling Shareholders . Each Selling Shareholder shall be
entitled to receive:
(1) At
the Closing - the product of the Per Share Series C Amount
multiplied by the total number of Series C Preferred Shares held by
such Selling Shareholder on the Closing Date, plus the
product of the Per Share Series B Amount multiplied by the number
of Series B Preferred Shares held by such Selling Shareholder on
the Closing Date, plus the product of the Per Share Series
A-3 Amount multiplied by the total number of Series A-3 Preferred
Shares held by such Selling Shareholder on the Closing Date,
plus the product of the Per Share Series A-1 Amount
multiplied by the total number of Series A-1 Preferred Shares held
by such Selling Shareholder on the Closing Date, plus the
product of the Per Share Series Ordinary A Amount multiplied by the
total number of Series Ordinary A Shares held by such Selling
Shareholder on the Closing Date (the sum of this
subsection 2.03(a)(1) – for each Selling Shareholder
shall be referred to herein as the “ Selling
Shareholder’s Preferred Amount ” and for the
aggregate amount of all Selling Shareholder's Preferred Amount, the
“ Preference Amount ”);
For purpose of this Agreement; the “
Per Share Series C Amount ” means an amount equal to
$ 1.5299 per share of Series C Preferred Shares; the “
Per Share Series B Amount ” means an amount equal to
$ 1.08946 per share of Series B Preferred Shares; the “
Per Share Series A-3 Amount ” means an amount equal to
$ 1.08946 per share of Series A-3 Preferred Shares; the
“ Per Share Series A-1 Amount ” means an amount
equal to $ 13.6542 per share of Series A-1 Preferred Shares;
and the “ Per Share Series Ordinary A Amount ”
means an amount equal to $ 3.6316095 per share of Series
Ordinary A Shares;; plus in each such per share amount above (other
than the Ordinary A Shares) the amount of interest accrued and
applicable to each such Company Shares calculated as of November
30, 2009, as set forth in the Consideration Allocation Spreadsheet.
The Preference Amount shall be $35,344,209.
(2) At
the Closing - the product of the Per Share Ordinary Amount
multiplied by the sum of (i) the total number of Ordinary Shares
held by such Selling Shareholder on the Closing Date, plus (ii) the
total number of Ordinary Shares issuable upon conversion of all
Series Ordinary A Shares, Series A-1 Preferred Shares, Series A-3
Preferred Shares, Series B Preferred Shares and Series C Preferred
Shares held by such Shareholder on the Closing Date, as set forth
opposite the name of such Shareholder on the Consideration
Allocation Certificate.
The Per Share Ordinary Amount will be calculated
as follows:
(i) The
Aggregate Consideration Value minus the Preference Amount shall be
referred to herein as the “ Aggregate Participating
Amount ”.
(ii) The
quotient obtained by dividing the Aggregate Participating Amount by
the " Fully Diluted Equity Securities " (which is equal to
the total number of Participating Shares plus the total number of
Vested Company Options which are outstanding as of the Closing Date
plus the total number of Company Ordinary Shares that are subject
to the Unvested Company Option assumed by Purchaser pursuant to the
terms of this Agreement), shall be defined as the " Per Share FD
Amount ".
(iii) The
“ Participating Rights Holders Participating
Amount” shall be equal to the Aggregate Participating
Amount minus the product obtained by multiplying the Unvested
Company Options by the Per Share FD Amount (i.e., the Value of
Unvested Company Options”).
(iv) The
quotient obtained by dividing (A) the Participating Rights Holders
Participating Amount plus the Aggregate Exercise Amount, by (B) the
Participating Shares plus the total number of Vested Company
Options, shall be defined as the “ Per Share Ordinary
Amount ”. In this Agreement, the “ Aggregate
Exercise Amount ” shall mean the amount which would have
been obtained if the total number of Vested Company Options had
been exercised in full into Company Shares. For clarification
purposes, the Aggregate Exercise Amount will not be actually paid
by the holders of Vested Company Options, nor will it be added to
the Closing Cash Consideration, but rather used for calculation
purposes only in order to determine the Per Share Ordinary
Amount.
The total number of shares held by each Selling
Shareholder and which are referred to in subsection 2.03(a)(2)(i)
and 2.03(a)(2)(ii) above shall be referred to as the “
Selling Shareholder’s Participating Shares ” and
for all Selling Shareholders the “ Participating
Shares ”; The amount or value each Selling Shareholder
shall be entitled to receive pursuant to this
subsection 2.03(a)(2) shall be referred to as the “
Selling Shareholder’s Participating Amount ” and
for all Selling Shareholders the “Shareholders
Participating Amount ”.
The total amount each Selling Shareholder will
be entitled to receive shall be equal to such Selling
Shareholder’s Participating Amount plus such Selling
Shareholder’s Preferred Amount, if any (the “
Selling Shareholder’s Closing Payment Amount ”),
subject to the provisions of Section 2.5 and Article XI
below.
The “ Closing Payment Value ”
means an amount equal to the Aggregate Consideration Value minus
the Value of Unvested Company Options.
The quotient obtained by dividing (i) (A) the
Value of the Closing Consideration Shares plus (B) the Value of the
Phantom Shares, by (ii) the Closing Payment Value will be referred
to herein as the “ Equity Portion ”; and the
quotient obtained by dividing (i) Closing Cash Consideration minus
the Vested Options Adjustment Amount, by (ii) the Closing Payment
Value shall be referred to herein as the “ Cash
Portion ”. In this Agreement the “ Value of the
Closing Consideration Shares ” means an amount equal to
the Closing SD Share Price multiplied by the total number of
Closing Consideration Shares; and the " Value of the Phantom
Shares " means an amount equal to the Closing SD Share Price
multiplied by the total number of Phantom Shares.
The proportion between the Closing Consideration
Shares and the Closing Cash Consideration each Selling Shareholder
will be entitled to receive at the Closing, will be based on the
ratio between the Cash Portion and the Equity Portion (the “
Distribution Ratio ”).
The number of Closing Consideration Shares each
Selling Shareholder will be entitled to receive shall be equal to
such Selling Shareholder’s Closing Payment Amount multiplied
by a fraction the numerator of which is equal to the Equity Portion
and the denominator is equal to the Closing SD Share
Price.
The number of Closing Consideration Shares and
the portion of the Cash Consideration each Selling Shareholders
will be entitled to receive at the Closing shall be set forth in
the Consideration Allocation Certificate.
(b)
Holder’s of Vested Company Options :
(1) At
the Closing, each holder of a Vested Company Option, by virtue of
the Transactions without any action on the part of the holder,
shall be entitled to receive in exchange for such Vested Company
Option an amount in cash equal to the product of Per Share Ordinary
Amount multiplied by the total number of Ordinary Shares issuable
upon a cashless exercise (i.e. using the Per Share Ordinary Amount)
of such Optionholder’s Vested Company Option (“
Optionholder’s Closing Payment Amount
”).
The Purchaser's Shares that all holders of
Vested Company Options would have been entitled to receive, if such
Optionholders had exercised their Vested Company Options into
Company Shares (on a cashless basis) is defined as the " Phantom
Shares ". The number of Phantom Shares each holder of Vested
Company Options would have been entitled to receive if such
Optionholder would have exercised his, her or its Vested Company
Options, shall be equal to such Optionholder’s Closing
Payment Amount multiplied by a fraction the numerator of which is
equal to the Equity Portion and the denominator is equal to the
Closing SD Share Price.
For clarification purposes (i) the Phantom
Shares are not issuable and will not be issued to the holders of
Vested Company Options and in lieu of such Phantom Shares such
holders of Vested Company Options will be entitled to receive an
amount in cash equal to such Optionholder's respective number of
Phantom Shares multiplied by the Closing SD Share Price; and (ii)
the total amount payable to all holders of Vested Company Options
pursuant to this sub-section shall be equal to the Vested Options
Adjustment Amount.
(2) Payments
made to each holder of Vested Company Options will be made to the
Trustee through the Paying Agent in accordance with Section 2.10
below;
(3) The
amount of Cash Consideration each holder of Vested Company Options
will be entitled to receive pursuant to the terms of this Agreement
shall be set forth in the Consideration Allocation
Certificate.
(c)
Holder’s of Unvested Company Option
(1) At
the Closing, Purchaser shall assume the unvested portion of each
Company Option outstanding as of the Closing Date (the “
Unvested Company Options ”). Each Unvested Company
Option will be exercisable (or will become exercisable in
accordance with its terms) for that number of whole Consideration
Shares equal to the number of Company Ordinary Shares that were
subject to the Unvested portion of such Company Option immediately
prior to the Closing Date multiplied by the ratio of the Per Share
FD Amount to the Closing SD Share Price (such ratio, the “
Option Ratio ”), rounded down to the nearest whole
number of Consideration Shares (and the per share exercise price
for the Consideration Shares issuable upon exercise of such assumed
Unvested Company Option will be equal to the quotient obtained by
dividing the exercise price per Company Ordinary Share at which
such Unvested Company Option was exercisable immediately prior to
the Closing Date by the Option Ratio, rounded up to the nearest
whole cent). The “ Value of Unvested Company Options
” shall mean the product obtained by multiplying the Unvested
Company Options by the Per Share FD Amount.
(2)
The number of Consideration Shares issuable pursuant to this
Section 2.03(c) shall be referred to as the “
Purchaser’s Equity Awards ”. The
number of Purchaser's Equity Awards each holder of Unvested Company
Options will be entitled to receive pursuant to the terms of this
Agreement, shall be set forth in the Consideration Allocation
Certificate.
(d)
Company Warrantholders .
(1) The
Company Warrants outstanding at the Closing will either be
terminated or exercised into Company Shares immediately prior to
the Closing.
(2) The
number of and class of Company Shares each Warrantholder will be
entitled to receive upon exercise or termination of such Warrants
as well as the number Closing Consideration Shares and the portion
of the Cash Consideration each holder Warrantholder will be
entitled to receive at the Closing upon the cashless exercise of
such Warrants, shall be set forth in the Consideration Allocation
Certificate.
(3) For
clarification purposes the parties acknowledge that for purposes of
this Section 2.03 and the calculation of the amount distributed to
each Equityholder, the Warrantholders will deemed to be, and are
treated as, Selling Shareholders (and the formulas set forth above
should include the number of Company Shares issuable upon a
cashless exercise of such Warrants).
(e)
Clarifications; Mechanics . Anything to the contrary
notwithstanding:
(1) Out
of the total number of Closing Consideration Shares, ninety percent
(90%) shall be issued to the Selling Shareholders and the balance
of ten percent (10%) will be issued for the benefit of the Selling
Shareholders yet set aside in the Escrow Fund (the " Share
Component of the Escrow Fund ") as further described in this
Section 2 and subject to forfeiture in accordance with Article XI.
Notwithstanding anything to the contrary contained herein, in no
event will the total number of Consideration Shares issued or
issuable by Purchaser pursuant to this Agreement, including all
Closing Consideration Shares and all Purchaser's Equity Awards,
equal more than the Maximum Consideration Shares.
(2) Out
of the Closing Cash Consideration payable at Closing, Purchaser
shall extend to the Escrow Agent: (i) an amount in cash equal to
ten percent (10%) of the Closing Cash Consideration (the " Cash
Component of the Escrow Fund "); and (ii) an amount in cash
equal to $200,000 as the Rep Reimbursement Amount - as further
described in this Section 2, and the balance of Closing Cash
Consideration will be paid to the Participating Rights Holders in
accordance with the terms hereof. In addition, and with respect to
each Participating Rights Holder, severally and not jointly,
Purchaser may deduct any withholding amounts as further described
in this Section 2.
(3) The
Purchaser or any of its Representatives shall not be responsible
for the determination of the Aggregate Consideration allocation.
The Aggregate Consideration allocation will be presented in the
Consideration Allocation Certificate, which will be deemed a
Specified Representation of the Company. The Company also
represents that the information and calculations set forth in the
Consideration Allocation Certificate shall be made in accordance
with the terms and conditions of this Agreement, the
Company’s Articles of Association, and other relevant
existing contractual arrangements among the Company, the holders of
Company Shares, Company Optionholders and Company Warrantholders.
Anything to the contrary notwithstanding, Purchaser shall be
entitled to rely entirely upon the Consideration Allocation
Certificate in connection with making the payments pursuant to this
Agreement and neither the Holder Representatives nor any
Equityholder shall be entitled to make any claim in respect of the
allocation of the payments made by Purchaser to or for the benefit
of any Equityholders to the extent that the payments are made in a
manner consistent with the Consideration Allocation
Certificate.
(4) The
Purchaser will make the payments pursuant this Agreement with the
assistance of a Payment Agent. Purchaser shall cause, and be
responsible for, the Payment Agent, to make the payment of the
Closing Cash Consideration to the holders of Company Shares and
Vested Company Options in accordance with the provisions set forth
in this Agreement and the Consideration Allocation
Certificate.
(5) Anything
in this Agreement to the contrary notwithstanding, no fractions of
a cent will be payable hereunder and any amounts payable hereunder
shall be rounded down to the nearest whole cent and no fractional
shares shall be issued hereunder and any fractional shares shall be
rounded down to the nearest whole share.
(6) Notwithstanding
anything to the contrary in this Agreement, and subject to the
potential additional payment pursuant to the terms of Section 7.05
hereof, the aggregate maximum consideration that Purchaser shall be
required to pay to all of the Equityholders pursuant to this
Agreement shall in no event exceed an aggregate value of
$160,000,000 plus the amount of Company Cash held by the Company on
the Closing Date, with all shares of Purchaser’s Shares
issued or to be issued pursuant to the terms of this Agreement
deemed to have, for the purpose of this sub-section 2.03(e)(6)
only, a stipulated value of the Average SD Share Price, minus the
amount of Company Debt on the Closing Date minus the Company
Transaction Expenses set forth in the Transaction Expenses
Certificate.
(f)
WAIVER AND RELEASE OF CLAIMS .
(1) Effective
for all purposes as of the date hereof, each Executing Shareholder
acknowledges and agrees on behalf of itself and each of its agents,
trustees, beneficiaries, directors, officers, affiliates,
subsidiaries, estate, successors and assigns (each, a “
Releasing Party ”) that each hereby releases and
forever discharges the Company, each Equityholder and the Purchaser
(each a “ Beneficiary ”) and each of such
Beneficiary’s respective subsidiaries, affiliates, directors,
officers, employees, representatives, agents, members,
stockholders, successors, predecessors and assigns (each, a “
Released Party ” and collectively, the “
Released Parties ”) from any and all Equityholder
Claims such Releasing Party may have or assert it has against any
of the Released Parties, from the beginning of time through the
time of the Closing and following the Closing, in each case whether
known or unknown, or whether or not the facts that could give rise
to or support a Claim are known or should have been known. In this
Agreement an “ Equityholder Claim ” shall mean:
(i) any claim or right to receive any Company Shares other
than the Company Shares set forth opposite his, her or its name in
the Estimated Consideration Allocation Chart (other than as a
result of an exercise of any Company Warrant outstanding as of
immediately prior to the Closing by any Executing Shareholder who
is a Company Warrantholder); (ii) any claim or right to receive any
portion of the Cash Consideration, Consideration Shares
or any other form, amount or value of consideration payable or
issuable to any Equityholder pursuant to the terms of this
Agreement, other than as specifically set forth in the
Consideration Allocation Certificate (subject to any changes
contemplated in this Agreement – e.g. as a result of changes
in the Company Cash, Company Debt, the vesting of any Unvested
Company Option or the exercise of any Company Warrant outstanding
as of immediately prior to the Closing by any Company
Warrantholder) and applicable to such Executing Shareholder; or
(iii) any claim with respect to the authority to enter into the
Transactions and the enforceability of the Transactions.
(2) Each
Executing Shareholder hereby confirms,
acknowledges, represents and warrants that he, she or
it: (A) (i) is the holder of the number of Company Shares set forth
opposite his, her or its name in the Estimated Consideration
Allocation Chart; (ii) other than the number and class of Company
Shares set forth opposite his, her or its name in the Estimated
Consideration Allocation Chart, is not entitled to any
additional Company Shares (other than as a result of an
exercise of any Company Warrant outstanding as of immediately prior
to the Closing by any Executing Shareholder who is a Company
Warrantholder) or any other form of equity securities
including, shares, options, warrants or any other convertible
security, or right to acquire shares, options or warrants of or any
other convertible security into share capital of the Company; (iii)
waives any right to receive any additional Company Shares (as a
result of any anti-dilution rights, preemptive rights, conversion
rights (of any of the Company Shares which are outstanding as of
the date hereof or any Company Shares he, she or it may have been
entitled to receive as a result of the conversion of any
convertible loan agreement or any other convertible instrument that
was issued by the Company), rights of first offer, co-sale and
no-sale rights, any other participation, first refusal or similar
rights, any adjustment of the conversion price of any preferred
share whatsoever) or otherwise), except for any additional Company
Shares issued as a result of an exercise of any Company Warrant
outstanding as of immediately prior to the Closing by any Company
Warrantholder; (iv) fully, finally, irrevocably and
forever waives any right to convert any of its Company Shares
into any other class or series of Company Shares presently and
through the Closing; and (B) (i) examined the Estimated
Consideration Allocation Chart and is entitled only to the
distribution set forth in such a chart (subject to any changes
contemplated in this Agreement – e.g. as a result of changes
in the Company Cash, Company Debt, the vesting of any Unvested
Company Option or the exercise of any Company Warrant outstanding
as of immediately prior to the Closing by any Company
Warrantholder); (ii) waives any right to receive consideration
other than as set forth in the Consideration Allocation Certificate
(including, without limitation, for any interest payments, the
method of determination of the Preference Amount and the Aggregate
Participating Amount, the method of calculation of any of the
values set forth in this Agreement or the method of determination
of the Participating Rights Holder's Interest,, any preferential
amount, any amount resulting from the conversion of shares any
other rights of any nature under the Articles of Association, or
any Shareholders Agreement, which the Executing Shareholders and/or
its successors and assignees ever had, now have or hereafter can,
shall or may have, at any time, due to actions or events that
occurred prior to Closing which do not conform or are not
consistent with the terms of this Agreement and the consideration
attributed to such Executing Shareholders in the Consideration
Allocation Certificate); (C) hereby terminates and waives any
rights, powers and privileges such Executing Shareholder has or may
have pursuant to any Shareholders Agreement (which for purposes of
this Agreement will be defined as any investors rights agreement,
registration rights agreement or shareholders agreement entered
into by such Executing Shareholders with respect to the Company) or
any right to make a claim or demand for any discrepancy between any
Shareholders Agreement, share purchase agreement or convertible
loan agreement such Executing Shareholder and the provisions of
this Agreement and his, her or its entitlement pursuant to such
agreements; (D) for as long as this Agreement is in force agrees
not to sell, transfer, assign or convert any of its Company Shares,
or subject such Company Shares to any Liens, except pursuant to a
transfer request of Company Shares provided to the Company and
Purchaser prior to the date hereof; and (E) has not heretofore
assigned or transferred, or purported to have assigned or
transferred, to any corporation (or any other legal entity) or
person whatsoever, any claim, debt, liability, demand, obligation,
cost, expense, action or cause of action herein
released.
(3) Each
Executing Shareholder hereby acknowledges that such Executing
Shareholder is familiar with Section 1542 of the Civil Code of the
State of California (“ Section 1542 ”), which
provides as follows:
A GENERAL
RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW
OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING
THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY
AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.
Effective for all purposes as of the date
hereof, each Executing Shareholder waives and relinquishes on
behalf of each Releasing Party any rights and benefits which such
Releasing Party may have under Section 1542 or any similar statute
or common law principle of any jurisdiction. Each
Executing Shareholder acknowledges that such Executing Shareholder
may hereafter discover facts in addition to or different from those
which such Executing Shareholder now knows or believes to be true
with respect to the subject matter of this Agreement, but it is
such Executing Shareholder’s intention to fully and finally
and forever settle and release any and all matters, disputes and
differences, known or unknown, suspected and unsuspected, which do
now exist or may exist or heretofore have existed between any
Releasing Party and any Released Party with respect to the subject
matter of this Agreement. In furtherance of this
intention, the releases herein shall be and remain in effect as
full and complete general releases notwithstanding the discovery or
existence of any such additional or different facts.
(4) Each
Executing Shareholder, on behalf of each Releasing Party, further
covenants and agrees that such Releasing Party has not heretofore
sold, transferred, hypothecated, conveyed or assigned, and shall
not hereafter sue any Released Party upon, any Equityholder Claim
released under this Section 2.03(f), and that each Releasing Party
shall indemnify and hold harmless the Released Parties against any
loss or liability on account of any actions brought by such
Releasing Party or such Releasing Party’s assigns or
prosecuted on behalf of such Releasing Party and relating to any
Equityholder Claim released under this Section 2.03(f).
(5) Notwithstanding
anything in this Section 2.03(f), the foregoing releases and
covenants shall not apply to any claims (a) relating to
Purchaser’s failure to pay the Closing Cash Consideration, to
issue the Consideration Shares or any other payments in accordance
with this Agreement; (b) relating to Purchaser’s failure to
perform any of its obligations, undertakings or covenants set forth
in this Agreement (including, without limitation the filing of the
Registration Statement on Form S-8 and indemnification obligations)
or any of the Transactional Agreements; (c) relating to any
employment payment, including salary, bonuses, accrued vacation,
any other employee compensation and/or benefits, and unreimbursed
expenses or any of the amounts set forth in Section 7.05 (
Bonus/ Retention Pool ), (d) relating to or arising from any
commercial relationship such Executing Shareholder may have with
any of the Released Parties; and (e) for indemnity by officers,
employees and directors of the Company in their capacity as such in
accordance with Section 7.07 below.
(6) Anything
to the contrary notwithstanding: (i) the foregoing release is
conditioned upon the consummation of the Closing and shall become
null and void, and shall have no effect whatsoever, without any
action on the part of any person or entity, upon termination of
this Agreement in accordance with its terms; and (ii) should any
provision of this release be found, held, declared, determined, or
deemed by any court of competent jurisdiction to be void, illegal,
invalid or unenforceable under any applicable statute or
controlling law, the legality, validity, and enforceability of the
remaining provisions will not be affected and the illegal, invalid,
or unenforceable provision will be deemed not to be a part of this
Release.
Section
2.04
[Reserved] .
Section
2.05
Escrow Fund .
(a)
Escrow Deposit . At the Closing, Purchaser shall issue and
deliver to the Escrow Agent, as the escrow agent under the Escrow
Agreement, the Cash Component of the Escrow Fund in US dollars in
immediately available funds and shall deliver the Share Component
of the Escrow Fund constituting the Escrow Fund to be held by the
Escrow Agent in accordance with the terms of the Escrow Agreement
and released from the Escrow Fund pursuant to the terms of this
Agreement and the Escrow Agreement. For all purposes of the Escrow
Fund, including the calculation of any payment to Purchasers for
Damages in accordance with Article XI below, the value of each
Consideration Share held in the Escrow Fund shall be calculated
using the Average SD Share Price. The “ Value of the
Escrow Fund ” shall be equal to the product of the
aggregate Share Component of the Escrow Fund multiplied by the
Average SD Share Price, plus the aggregate Cash Component of the
Escrow Fund.
(b) Any
amount paid from the Escrow Fund to Purchaser in accordance with
Article XI shall be paid to Purchaser in (i) cash and (ii) a number
of Consideration Shares, in proportion to the ratio between the
Cash Component of the Escrow Fund and the Share Component of the
Escrow Fund, assuming a value for each such Consideration Share
equal to the Average SD Share Price.
(c)
Participating Rights Holder’s Interest . Each
Participating Rights Holder portion in the Escrow Fund shall be
calculated as the quotient obtained by dividing each Participating
Rights Holder's Cash Component of the Escrow Fund, plus such
Participating Rights Holder's Share Component of the Escrow Fund,
if any (calculated based on the Average SD Share Price), by the
Value of the Escrow Fund Each Participating Rights
Holder’s Interest in the Escrow Fund and the number of
Consideration Shares and the portion of the Cash Consideration set
aside in Escrow Fund, shall be set forth in the Consideration
Allocation Certificate.
(d) Any
amount distributed out of the Escrow Fund shall be allocated to
each Participating Rights Holder according to such Participating
Rights Holder's Interest in the Escrow Fund (it being understood
that the Share Component of the Escrow Fund shall be distributed
only to the Selling Shareholders, and in accordance with the
aforementioned such Participating Rights Holder's
Interest.
Section 2.06
Non Executing Shareholders' Deposit .
(a) Anything
in this Agreement to the contrary notwithstanding, if the Purchaser
elects to exercise its rights to provide the Bring-Along Notice
under Section 2.02(b)(3) of this Agreement, Purchaser shall
transfer to the Paying Agent the appropriate portion out of the
Closing Consideration Shares and the Closing Cash Consideration
payable under this Agreement to all Non Executing Shareholders,
subject to any applicable amount to remain in the Escrow Fund in
accordance with Section 2.05 (the “ Non-Executing
Shareholder’s Deposit ”). Such amounts will be held
by the Paying Agent in trust for and to the benefit of each such
Non Executing Shareholders, until such Non Executing Shareholder
shall have become an Execution Shareholder hereunder by executing
and delivering to Purchaser this Agreement and the other
Transaction Documents to be executed by it and otherwise delivering
to Purchaser all other deliveries called for herein. As soon as
practicable thereafter, the Paying Agent shall transfer to such Non
Executing Shareholder who has become an Executing Shareholder his,
her or its appropriate portion held in such assets and funds. The
foregoing shall also apply, mutatis mutandis , to the
appropriate portion of any sums released from the Escrow Agent in
accordance with the Escrow Agreement. Should a
Non-Executing Shareholder not execute the aforementioned within
three months of the Bring-Along Notice, then the Purchaser may
direct the Paying Agent to transfer such Non-Executing
Shareholder’s Deposit to the Company. Thereafter,
such Non-Executing Shareholder shall look only to the Company for
the Non-Executing Shareholder’s Deposit.
Section
2.07
Holder Representative Reimbursement Amount .
A portion of the Closing Cash Consideration
otherwise payable to the Participating Rights Holders equal to
$200,000 (the “ Rep Reimbursement Amount ”),
shall not be paid at the Closing to the Participating Rights
Holders, but shall instead be deposited with the Escrow Agent, to
be used by the Holder Representatives for the payment of expenses
incurred by each of the Holder Representatives in performing his
duties pursuant to this Agreement. The portion of the Closing Cash
Consideration to be contributed on behalf of each Participating
Rights Holder hereunder to the Rep Reimbursement Amount shall be
based on the Participating Rights Holder’s Interest. The Rep
Reimbursement Amount shall in no manner affect or impact the amount
of the Escrow Fund. In the event that the Holder Representatives
have not used the entire Rep Reimbursement Amount at such time as
the termination of the Escrow Period, any remaining amount shall be
distributed by the Escrow Agent to the Participation Rights Holders
pro rata to their respective Participating Rights Holder’s
Interests. The Rep Reimbursement Amount, or any portion thereof,
will be distributed to the Participating Rights Holders in
accordance with the terms of the Escrow Agreement and such
distribution shall be based on the Participating Rights Holder's
Interest. If the Rep Reimbursement Amount shall be
insufficient to reimburse each of the Holder Representatives’
expenses in accordance with this Agreement, then upon written
request of the Holder Representatives, each Participating Rights
Holder shall make a payment of its respective share of such
additional expenses to the Holder Representatives, based on such
Participating Rights Holder’s Interest; provided, however,
that any additional payment by each Participating Rights Holder
shall not impact any of the obligations of each Participating
Rights Holder pursuant to Article XI below.
Section
2.08
Consideration Charts .
(a)
Estimated Consideration Allocation Chart . Prior to the date
hereof, the Company provided the Purchaser and the Holder
Representatives with the Estimated Consideration Allocation Chart
(attached hereto as Exhibit K ) illustrating the respective
distribution of the consideration at Closing Date based on certain
hypothetical assumptions and conditions. The Estimated
Consideration Allocation Chart is not intended in any way to set
forth the amounts that will actually be payable to the
Equityholders pursuant to this Agreement, and is merely an
illustration of how to calculate the amount due to each
Equityholder based on the methodology set forth above.
(b)
Consideration Allocation Certificate . Not later than three
(3) Business Days before the Closing, the Company shall deliver to
Purchaser and the Holder Representatives a certificate of the
Company (the “ Estimated Company Pre-Closing
Certificate ”) executed on its behalf by the Chief
Financial Officer of the Company that sets forth in reasonable
detail the Company’s estimate of the Closing Cash, together
with copies of the Company bank statements supporting such
estimation (“ Estimated Closing Cash ”). The
Estimated Company Pre-Closing Certificate will be amended and
delivered to Purchaser one (1) Business Day before the Closing, to
reflect any changes in the Closing Cash. The adjusted certificate
will be referred to herein as the “ Closing Cash
Certificate ”. The amounts set forth in the Closing Cash
Certificate shall be incorporated in the Consideration Allocation
Certificate. The Closing Cash Certificate shall be executed by the
Chief Executive Officer and Chief Financial Officer of the Company
and shall be deemed to be a representation and warranty of the
Company with respect to the amount of Cash held by the Company at
Closing. The Consideration Allocation Certificate, as adjusted to
reflect the Closing Cash Certificate (the “ Consideration
Allocation Certificate ”) shall be delivered together
with the Closing Cash Certificate and shall be executed by the
Chief Executive Officer and Chief Financial Officer of the Company,
and by the Holder Representatives, and shall be deemed to be a
representation and warranty of the Company and each of the Selling
Shareholders with respect to his, her or its entitlement to
distribution hereunder. In no event shall Purchaser be required to
make any payments pursuant to this Agreement unless and until the
Consideration Allocation Certificate has been duly executed and
delivered by the Company and the Holder Representatives. Purchaser
shall be entitled to rely entirely upon the Consideration
Allocation Certificate in connection with making the payments
pursuant to this Agreement and neither the Holder Representatives
nor any Equityholder shall be entitled to make any claim in respect
of the allocation of the payments made by Purchaser to or for the
benefit of any Equityholders to the extent that the payments are
made in a manner consistent with the Consideration Allocation
Certificate.
(c)
Recapitalization . If between the date of this Agreement and
the Closing, the number of outstanding Ordinary Shares or
Preferred Shares is changed into a different number of shares
or into a different class, by reason of any share dividend,
subdivision, reclassification, recapitalization, split-up,
combination, exchange of shares, or the like, the
per Company Share, and per Company Option amounts set out in
this Agreement will be correspondingly adjusted to reflect such
change, such that the Aggregate Consideration shall not be
increased or reduced as a result of any such action.
Section
2.09
Legend Requirement .
(a)
Securities Act . Each certificate representing the Closing
Consideration Shares shall (unless otherwise permitted by the
provisions of this Agreement) be imprinted with a legend
substantially similar to the following (in addition to any legend
required under applicable securities laws or as provided elsewhere
in this Agreement):
For Regulation D Investors:
“THE SECURITIES REPRESENTED HEREBY HAVE
BEEN ACQUIRED PURSUANT TO REGULATION D OF THE SECURITIES ACT OF
1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD,
MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT IN
ACCORDANCE THEREWITH, PURSUANT TO A REGISTRATION UNDER THE ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. THE ISSUER OF
THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY
PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS. IN ADDITION, NO HEDGING
TRANSACTION MAY BE CONDUCTED WITH RESPECT TO THESE SECURITIES
UNLESS SUCH TRANSACTIONS ARE IN COMPLIANCE WITH THE
ACT.”
For Regulation S Investors:
“THE SECURITIES REPRESENTED HEREBY HAVE
BEEN ACQUIRED PURSUANT TO REGULATION D OF THE SECURITIES ACT OF
1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD,
MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT IN
ACCORDANCE THEREWITH, PURSUANT TO A REGISTRATION UNDER THE ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. THE ISSUER OF
THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY
PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS. IN ADDITION, NO HEDGING
TRANSACTION MAY BE CONDUCTED WITH RESPECT TO THESE SECURITIES
UNLESS SUCH TRANSACTIONS ARE IN COMPLIANCE WITH THE
ACT.”
For all Principal Shareholders:
“THE SECURITIES REPRESENTED BY THIS
CERTIFICATE WERE ISSUED PURSUANT TO THE ACQUISITION AGREEMENT DATED
OCTOBER 12, 2009 BY AND AMONG SIGMA DESIGNS, INC., COPPERGATE
COMMUNICATIONS LTD., AND CARMEL V.C. 2 LTD. AND TAMIR FISHMAN
VENTURES MANAGEMENT II LTD., AS THE HOLDER REPRESENTATIVES, AND
EACH PERSON IDENTIFIED ON EXHIBIT A-1 THERETO (THE
“ACQUISITION AGREEMENT”) AND ARE SUBJECT TO CERTAIN
RESTRICTIONS (THE “LOCK-UP RESTRICTIONS”) ON TRANSFER
SET FORTH IN A LOCK-UP AGREEMENT DATED OCTOBER 12, 2009, IN FAVOR
OF SIGMA DESIGNS, INC. THE LOCK-UP RESTRICTIONS SHALL
EXPIRE AS TO TWENTY-FIVE PERCENT (25%) OF THE TOTAL SECURITIES
ISSUED TO THE HOLDER OF THIS CERTIFICATE PURSUANT TO THE
ACQUISITION AGREEMENT ON THE LATER OF (I) THE SECOND BUSINESS DAY
FOLLOWING THE FIRST PUBLIC ANNOUNCEMENT, RELEASE OR FILING OF
EARNINGS OF SIGMA DESIGNS, INC. FOLLOWING THE CLOSING DATE OF SIGMA
DESIGNS, INC.’S ACQUISITION OF COPPERGATE COMMUNICATIONS
LTD., OR (II) THE DATE ON WHICH THE REGISTRATION STATEMENT PURSUANT
TO WHICH THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE
REGISTERED FOR RESALE IN ACCORDANCE WITH THE ACQUISITION AGREEMENT
IS DECLARED EFFECTIVE (SUCH LATER DATE, THE “INITIAL RELEASE
DATE”). THEREAFTER, AN ADDITIONAL TWENTY-FIVE
PERCENT (25%) OF THE TOTAL SECURITIES ISSUED TO THE HOLDER OF THIS
CERTIFICATE PURSUANT TO THE ACQUISITION AGREEMENT WILL BE RELEASED
FROM THE LOCK-UP RESTRICTIONS ON EACH OF THE 60TH, 120TH AND 180TH
DAY FOLLOWING THE INITIAL RELEASE DATE.”
(b)
Blue Sky Laws . In addition, certificates representing the
Closing Consideration Shares may contain any legend required by the
blue sky laws of any jurisdiction to the extent such laws are
applicable to the sale of the Closing Consideration Shares
hereunder.
Section
2.10
Closing of the Company’s Share Registry
.
At the Closing Date, holders of certificates
representing Company Shares that were outstanding immediately prior
to the Closing Date shall cease to have any rights as shareholders
of the Company, and the share registry of the Company shall be
closed with respect to all shares outstanding immediately prior to
the Closing Date. No further transfer of any such Company Shares
shall be made on such share registry after the Closing
Date.
Section
2.11
Withholding Rights .
(a)
Right to Withhold . Each of Purchaser, the Paying Agent, the
Escrow Agent and the Company shall be entitled to deduct and
withhold from any consideration payable or otherwise deliverable to
any Equityholder, former Equityholder or other Person pursuant to
this Agreement such amounts as Purchaser, the Paying Agent, the
Escrow Agent or the Company, as the case may be, are required to
deduct or withhold therefrom under the Code, the Israeli Code, or
any Tax law, with respect to the making of such payment. To the
extent that such amounts are so withheld by Purchaser, the Paying
Agent, the Escrow Agent or the Company, as the case may be, (i)
such withheld amounts shall be treated for all purposes of this
Agreement as having been paid to the Person to whom or to which
such amounts would otherwise have been paid in respect of whom such
deduction and withholding was made by Purchaser, the Escrow Agent
or the Company, (ii) such withhel

|